Efficacy of tyrosine kinase inhibitors for the treatment of patients with HER2-positive breast cancer with brain metastases: a systematic review and meta-analysis.
ESMO Open. 2022 Jun;7(3):100501. doi: 10.1016/j.esmoop.2022.100501. Epub 2022 May 30.
ESMO Open. 2022.
PMID: 35653982
Free PMC article.
Review.